侵袭性霉菌感染与疾病流行病学格局的变化
本文综述侵袭性霉菌病流行病学格局的变迁:曲霉属仍是最常见病原,但烟曲霉复合群以外的曲霉及其他霉菌日益重要,烟曲霉唑类耐药成为新问题;毛霉目所致毛霉病可能被低估,因其对多种抗真菌药耐药性更强;部分三级医院中镰刀菌属可能仅次于曲霉,赛多孢子菌属亦为新现机会性病原。作者强调应在菌种水平准确鉴定病原体以指导个体化治疗。
要点
- 烟曲霉复合群仍是侵袭性霉菌病主要病原,但其唑类耐药问题日益突出。
- 毛霉目对伏立康唑均无效、多数对棘白菌素类体外中度耐药,毛霉病可能被低估。
- 侵袭性霉菌病应在菌种水平准确鉴定病原,以匹配各自不同的药敏谱并指导治疗。
核心结论
- 侵袭性霉菌病流行病学格局正在变化,非烟曲霉曲霉及其他霉菌日趋重要,菌种水平鉴定应视为标准诊疗。
研究设计与样本
- 综述性文章,汇总侵袭性霉菌感染病原谱与耐药性变化的文献证据,未报告系统检索范围与样本量。
主要发现
- 烟曲霉复合群是侵袭性霉菌病最常见病原之一,烟曲霉唑类耐药为新兴问题,其他曲霉属中已有两性霉素B耐药报道。
- 非烟曲霉曲霉与其他霉菌日益重要,但少见霉菌流行率缺乏汇总数据。
- 毛霉病发病率可能被低估,毛霉目对伏立康唑均无效、多数对棘白菌素类体外中度耐药。
- 部分三级医院中镰刀菌属可能为仅次于曲霉的第二常见院内真菌病原,耐药水平高于曲霉属。
- 近日有报道橙色赛多孢子菌为新现机会性病原,伏立康唑对其活性最强。
关键数值与推荐
- 毛霉目所有种对伏立康唑均无效,多数对棘白菌素类体外呈中度耐药。
- 任何侵袭性真菌病均应在种水平准确鉴定病原体,视为标准诊疗。
临床怎么用
- 临床遇侵袭性霉菌感染应尽量做到菌种水平鉴定,并据此结合各菌种固有药敏谱选择抗真菌治疗。
- 对疑似毛霉病需考虑其对伏立康唑无效,不能以伏立康唑覆盖。
- 对镰刀菌、赛多孢子菌等少见霉菌应警惕其耐药谱与曲霉不同,需个体化管理。
局限性
- 少见霉菌流行率缺乏汇总数据,毛霉病发病率可能被低估。
- 综述未报告系统检索策略与纳入研究数量,证据汇总方式不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although a wide variety of pathogens are associated with invasive mould diseases, Aspergillus spp. have historically been one of the most common causative organisms. Most invasive mould infections are caused by members of the Aspergillus fumigatus species complex and an emerging issue is the occurrence of azole resistance in A. fumigatus, with resistance to amphotericin B documented in other Aspergillus spp. The epidemiology of invasive fungal disease has shifted in recent years as non-A. fumigatus Aspergillus spp. and other moulds have become progressively more important, although there are no consolidated data on the prevalence of less common species of moulds. The incidence of mucormycosis may have been underestimated, which is a potential concern since species belonging to the order Mucorales are more resistant to antifungal agents than Aspergillus spp. All species of Mucorales are unaffected by voriconazole and most show moderate resistance in vitro to echinocandins. Fusarium spp. may be the second most common nosocomial fungal pathogen after Aspergillus in some tertiary hospitals, and show a susceptibility profile marked by a higher level of resistance than that of Aspergillus spp. Recently, Scedosporium aurantiacum has been reported as an emerging opportunistic pathogen, against which voriconazole is the most active antifungal agent. Other mould species can infect humans, although invasive fungal disease occurs less frequently. Since uncommon mould species exhibit individual susceptibility profiles and require tailored clinical management, accurate classification at species level of the aetiological agent in any invasive fungal disease should be regarded as the standard of care.
引用
- Lass-Flörl C, Cuenca-Estrella M. Changes in the epidemiological landscape of invasive mould infections and disease. J Antimicrob Chemother. 2017. PMID: 28355462. doi:10.1093/jac/dkx028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。